Chi-Tun Ruan

Title: Chi-Tun Ruan: Innovator in Pharmaceutical Composition

Introduction

Chi-Tun Ruan is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions that activate AMP-dependent protein kinase (AMPK). His work is crucial for advancing treatments for various diseases associated with cell growth and metabolism.

Latest Patents

Chi-Tun Ruan holds a patent for an isoquinoline alkaloid derivative aimed at activating AMPK. The patent describes a method for administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound, such as salsolinol or reticuline. This innovative composition is designed to effectively regulate cell growth and metabolism, providing potential therapeutic benefits for AMPK-associated diseases. He has 1 patent to his name.

Career Highlights

Ruan's career is marked by his dedication to research and innovation in biotechnology. His work at Zih Yuan Tang Biotechnology Co., Ltd. has positioned him as a key player in the development of new therapeutic strategies. His research focuses on the intersection of pharmacology and biochemistry, contributing to advancements in medical treatments.

Collaborations

Chi-Tun Ruan has collaborated with esteemed colleagues such as Sheng-Fa Tsai and Ming-Jai Su. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in biotechnology.

Conclusion

Chi-Tun Ruan's contributions to the field of biotechnology, particularly through his patent on AMPK activation, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of diseases related to cell growth and metabolism.